Drug profile · INN
repaglinide
REPAGLINIDE SUN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
repaglinide (REPAGLINIDE SUN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN repaglinide
Brand REPAGLINIDE SUN
Route ORAL
Formulation TABLET
ATC code A10BX02
Originator Teva Pharma GmbH
Frequently asked questions
What is repaglinide?
repaglinide (REPAGLINIDE SUN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for repaglinide?
REPAGLINIDE SUN is a marketed brand name for repaglinide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of repaglinide?
repaglinide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.